Study confirms flu vaccine effectiveness against A H1N1 in young children

A study published on Eurosurveillance has demonstrated that Spain’s influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections (ARI) and hospitalization, as vaccination was recommended for this age group at the national level for the first time.

AstraZeneca reveals first clinical data for bispecific T cell engager from TeneoTwo buyout

SAN DIEGO — AstraZeneca is getting ready to step on the gas in the world of bispecific T cell engagers. The company presented some of

December 9, 2024

Her hearing implant was preapproved. Nonetheless, she got $139,000 bills for months.

Caitlyn Mai woke up one morning in middle school so dizzy she couldn’t stand and deaf in one ear, the result of an infection that

July 17, 2024

After delay, Abeona aims for fall FDA submission for rare skin condition cell therapy

In June, Abeona pushed back the timeline for its application to the FDA for approval of a rare genetic skin cell therapy. At the time,

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.